Diffuse Large B-cell Lymphoma (Phase 2)
1 clinical trials · Condition
◉ Watch Diffuse Large B-cell Lymphoma (Phase 2)
| Record | Firm | Date |
|---|---|---|
| Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL (NCT01897571) | Epizyme, Inc. | 2013-06-13 |
Track Diffuse Large B-cell Lymphoma (Phase 2) automatically
Every clearance here is in the API, with alerts when new ones post.